AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Intraoperative Radiation Therapy Market - Global Forecasts to 2024 - ResearchAndMarkets.com

September 12, 2019

DUBLIN--(BUSINESS WIRE)--Sep 12, 2019--

The “Intraoperative Radiation Therapy Market by Method (Electron IORT, Intraoperative Brachytherapy), Products & Services (Accelerators, Treatment Planning System, Applicators, Afterloaders, Accessories), Application (Breast, Brain) - Global Forecasts to 2024” report has been added to ResearchAndMarkets.com’s offering.

The global intraoperative radiation therapy market is projected to reach USD 68 million by 2024 from USD 48 million in 2019, at a CAGR of 7.0%.

The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.

However, the complex nature of technology coupled with a shortage of trained personnel and preference of conventional radiotherapy over IORT by physicians owing to reimbursement coverage are the major factors that are expected to restrain the growth of this market.

The system/accelerators segment is expected to account for the largest market share during the forecast period

Based on product type, the intraoperative radiation therapy market products market is segmented into system/accelerators, treatment planning systems, applicators & after loaders, and accessories. The systems/accelerators segment is expected to account for the largest share of the IORT products market in 2019. The large share of this segment can be attributed to the low cost of accelerators as compared to advanced radiosurgery products, growing applications of IORT products in cancer treatment, and the development of technologically advanced mobile systems/accelerators.

The breast cancer segment is expected to hold the largest share of the intraoperative radiation therapy market, by application, during the forecast period

Based on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head & neck cancer, and other cancers. The breast cancer segment is expected to account for the largest share of this market in 2019. The large share of this segment can be attributed to a high prevalence of breast cancer, coupled with advantages offered by IORT such as the reduced amount of irradiation, shorter treatment time, and lesser clinical risks.

Market Dynamics

Drivers

Restraints

Opportunities

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/kquj90

View source version on businesswire.com:https://www.businesswire.com/news/home/20190912005455/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: RADIOLOGY HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 09/12/2019 06:52 AM/DISC: 09/12/2019 06:52 AM

http://www.businesswire.com/news/home/20190912005455/en

All contents © copyright 2019 The Associated Press. All rights reserved.